Literature DB >> 17955157

Clinical Trial Updates and Hotline Sessions presented at the European Society of Cardiology Congress 2007: (FINESSE, CARESS, OASIS 5, PRAGUE-8, OPTIMIST, GRACE, STEEPLE, SCAAR, STRATEGY, DANAMI-2, ExTRACT-TIMI-25, ISAR-REACT 2, ACUITY, ALOFT, 3CPO, PROSPECT, EVEREST, COACH, BENEFiT, MERLIN-TIMI 36, SEARCH-MI, ADVANCE, WENBIT, EUROASPIRE I-III, ARISE, getABI, RIO).

Michael Kindermann1, Oliver Adam, Nikos Werner, Michael Böhm.   

Abstract

This article provides information and commentaries on trials which were presented at the Hotline and Clinical Trial Update Sessions at the European Society of Cardiology Congress 2007 in Vienna. The key presentations were performed by leading experts in the field with relevant positions in the trials or registries. It is important to note that unpublished reports should be considered as preliminary data, as the analysis may change in the final publications. The comprehensive summaries have been generated from the oral presentation and the webcasts of the European Society of Cardiology and should provide the readers with the most comprehensive information of relevant publications.

Entities:  

Mesh:

Year:  2007        PMID: 17955157     DOI: 10.1007/s00392-0591-z

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  27 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Sirolimus-eluting versus uncoated stents in acute myocardial infarction.

Authors:  Christian Spaulding; Patrick Henry; Emmanuel Teiger; Kevin Beatt; Ezio Bramucci; Didier Carrié; Michel S Slama; Bela Merkely; Andrejs Erglis; Massimo Margheri; Olivier Varenne; Ana Cebrian; Hans-Peter Stoll; David B Snead; Christoph Bode
Journal:  N Engl J Med       Date:  2006-09-14       Impact factor: 91.245

3.  Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention.

Authors:  Gerrit J Laarman; Maarten J Suttorp; Maurits T Dirksen; Loek van Heerebeek; Ferdinand Kiemeneij; Ton Slagboom; L Ron van der Wieken; Jan G P Tijssen; Benno J Rensing; Mark Patterson
Journal:  N Engl J Med       Date:  2006-09-14       Impact factor: 91.245

4.  Predictors of response to cardiac resynchronization therapy (PROSPECT)--study design.

Authors:  Cheuk-Man Yu; William T Abraham; Jeroen Bax; Eugene Chung; Michelle Fedewa; Stefano Ghio; Christophe Leclercq; Angel R León; John Merlino; Petros Nihoyannopoulos; Dean Notabartolo; Jing Ping Sun; Luigi Tavazzi
Journal:  Am Heart J       Date:  2005-04       Impact factor: 4.749

5.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

6.  Effect of ramipril on the incidence of diabetes.

Authors:  Jackie Bosch; Salim Yusuf; Hertzel C Gerstein; Janice Pogue; Patrick Sheridan; Gilles Dagenais; Rafael Diaz; Alvaro Avezum; Fernando Lanas; Jeffrey Probstfield; George Fodor; Rury R Holman
Journal:  N Engl J Med       Date:  2006-09-15       Impact factor: 91.245

7.  Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

Authors:  Bo Lagerqvist; Stefan K James; Ulf Stenestrand; Johan Lindbäck; Tage Nilsson; Lars Wallentin
Journal:  N Engl J Med       Date:  2007-02-12       Impact factor: 91.245

8.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

9.  Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial.

Authors:  Francisco Fernandez-Avilés; Joaquín J Alonso; Alfonso Castro-Beiras; Nicolás Vázquez; Jesús Blanco; Juan Alonso-Briales; Juan López-Mesa; Felipe Fernández-Vazquez; Isabel Calvo; Luis Martínez-Elbal; José A San Román; Benigo Ramos
Journal:  Lancet       Date:  2004 Sep 18-24       Impact factor: 79.321

10.  Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.

Authors:  Adnan Kastrati; Julinda Mehilli; Franz-Josef Neumann; Franz Dotzer; Jurriën ten Berg; Hildegard Bollwein; Isolde Graf; Maryam Ibrahim; Jürgen Pache; Melchior Seyfarth; Helmut Schühlen; Josef Dirschinger; Peter B Berger; Albert Schömig
Journal:  JAMA       Date:  2006-03-13       Impact factor: 56.272

View more
  6 in total

1.  Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association.

Authors:  Jerome L Fleg; Daniel E Forman; Kathy Berra; Vera Bittner; James A Blumenthal; Michael A Chen; Susan Cheng; Dalane W Kitzman; Mathew S Maurer; Michael W Rich; Win-Kuang Shen; Mark A Williams; Susan J Zieman
Journal:  Circulation       Date:  2013-10-28       Impact factor: 29.690

2.  Hotlines and clinical trial updates presented at the European Society of Cardiology Meeting 2009: data from RE-LY, PLATO, MADIT-CRT, PROTECT, SYNTAX, TRITON and more.

Authors:  S H Schirmer; A M van der Laan; M Böhm; F Mahfoud
Journal:  Clin Res Cardiol       Date:  2009-11       Impact factor: 5.460

3.  Altered nitric oxide/cGMP platelet signaling pathway in platelets from patients with acute coronary syndromes.

Authors:  Loredana Bergandi; Marco Cordero; Matteo Anselmino; Gaetana Ferraro; Laura Ravera; Paola Dalmasso; Corrado Moiraghi; Gian Paolo Trevi; Dario Ghigo; Amalia Bosia; Serena Bergerone
Journal:  Clin Res Cardiol       Date:  2010-05-14       Impact factor: 5.460

4.  Angioplasty within 24 h after thrombolysis in patients with acute ST-elevation myocardial infarction: current use, predictors and outcome. Results of the MITRA plus registry.

Authors:  Oliver Koeth; Timm Bauer; Harm Wienbergen; Anselm Kai Gitt; Claus Juenger; Uwe Zeymer; Karl Eugen Hauptmann; Hans Georg Glunz; Udo Sechtem; Jochen Senges; Ralf Zahn
Journal:  Clin Res Cardiol       Date:  2008-11-04       Impact factor: 5.460

5.  ExTRACT-TIMI 25 in perspective: key lessons regarding enoxaparin as an adjunct to fibrinolytic therapy.

Authors:  Deepak Thomas; Robert P Giugliano
Journal:  J Thromb Thrombolysis       Date:  2008-10-19       Impact factor: 2.300

6.  CEPHEUS SA: a South African survey on the undertreatment of hypercholesterolaemia.

Authors:  F Raal; C Schamroth; D Blom; J Marx; M Rajput; M Haus; R Hussain; F Cassim; M Nortjé; G Vandehoven; A-M Temmerman
Journal:  Cardiovasc J Afr       Date:  2011-09-15       Impact factor: 1.167

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.